|
|
|
| Analysis on clinical medication of Professor Zhou Yabin in the treatment of chronic pulmonary heart disease |
| YUAN Ye1 FAN Zengguang1 WANG Yan2 YANG Jianfei2 |
1.The First Clinical Medical College, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China;
2.the Second Department of Cardiovascular Diseases, the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China |
|
|
|
Abstract Objective To analyze the medication rules of Professor Zhou Yabin in the treatment of chronic pulmonary heart disease through the medication statistics of Professor Zhou Yabin in the treatment of patients with chronic pulmonary heart disease. Methods The complete and effective medical records of patients with chronic pulmonary heart disease diagnosed and treated by Professor Zhou Yabin in the First Affiliated Hospital of Heilongjiang University of Chinese Medicine from September 2015 to August 2019 were collected. The database was established by using Excel software and SPSS 24.0 software, drug category, drug frequency and cluster analysis were carried out, and high frequency drug category, common Chinese medicine, drug pair and drug combination were obtained. Through statistical results, clinical medication characteristics of Professor Zhou Yabin in the treatment of chronic pulmonary heart disease were explored. Results In this study, a total of 97 compound prescriptions of Chinese materia medica of Professor Zhou Yabin for the diagnosis and treatment of chronic pulmonary heart disease were collected, involving 149 Chinese materia medica, of which, 27 were used more than 20 times, with a cumulative frequency of 68.29%. In the categories of drugies, the proportion of tonifying deficiency drugs, drugs for diuresis and diffusing dampness, warming interior medicine, drugs for dissipating phlegm and relieving cough and antiasthmatic, and blood activating and stasis removing drugs was larger, and the cumulative frequency was as high as 81.83%. Then the cluster analysis of the 27 traditional Chinese medicines was carried out, and three clustering formulas and six common drug pairs were obtained. Conclusion Professor Zhou Yabin’s internal prescriptions for treating chronic pulmonary heart disease are mainly benefiting qi and warming yang, ventilating lung qi and water circulation, promoting blood circulation and removing blood stasis, and the effect is significant.
|
|
|
|
|
|
[1] 宋彦伟，杨如意.中医药治疗慢性肺心病的研究进展[J].中西医结合心血管病电子杂志，2017，5（16）：177-178.
[2] 陶静怡.养心汤辅助治疗慢性肺心病急性发作120例[J].山东中医药大学学报，2013，37（1）：37-38.
[3] 徐桐柏，李冬生，胡国华，等.清肺消炎丸对肺心病患者免疫功能影响的临床研究[J].天津中医药，2016，33（11）：658-660.
[4] 孙诗佳，苏宏，邹本宏，等.新活素序贯芪苈强心胶囊治疗肺心病心衰疗效观察[J].辽宁中医药大学学报，2019， 21（2）：212-215.
[5] 徐文华，杨文娜，赵阳，等.基于网络药理学的小青龙汤治疗肺心病作用机制探讨[J].中华中医药杂志，2019，37（10）：2341-2345.
[6] 赵步长，赵涛，宋琳琳，等.丹红注射液治疗慢性肺源性心脏病的研究进展[J].中国循证心血管医学杂志，2017， 9（4）：494-495.
[7] 湛智杰.抗凝治疗在肺心病治疗中的应用观察[J].中国医药科学，2019，9（23）：282-285.
[8] 王岩，滕林，王红.中医药防治肺心病的研究进展[J].中医药信息，2016，33（6）：125-128.
[9] 娄明远，朱岚.中西医结合治疗老年肺心病急性加重期临床观察[J].中华中医药学刊，2018，36（7）：1783-1785.
[10] 李晓宇，王振亮，张文，等.从“随脏腑之性而治”探讨慢性肺源性心脏病[J].中华中医药杂志，2019，34（3）：1080-1083.
[11] 国家药典委员会.中华人民共和国药典[M].一部.北京：中国医药科技出版社，2015：1749.
[12] 邱新辉.补肾益气中药结合西药在缓解期肺心病临床治疗中的应用[J].医学理论与实践，2018，31（19）：2884-2886.
[13] 聂彤.肺心病急性加重期患者脑钠肽水平与凝血功能的相关性分析[J].血栓与止血学，2017，23（2）：298-302.
[14] 朱蕾蕾，孙继佳，金采映，等.基于数据库及数据挖掘的中医医案方法学研究——蒋健教授治疗胃痛的临床经验总结[J].中华中医药杂志，2013，28（10）：2888-2893.
[15] 曹丽娟，于玲，王凤儒，等.刘东方教授治疗慢性心力衰竭的临床经验[J].中国中医急症，2019，28（7）：1276-1278.
[16] 蒋微，蒋式骊，刘平.黄芪甲苷的药理作用研究进展[J].中华中医药学刊，2019，37（9）：2121-2124.
[17] 樊长征，洪巧瑜.党参对人体各系统作用的现代药理研究进展[J].中国医药导报，2016，13（10）：439-443.
[18] 范增光，王淑荣，周亚滨.周亚滨运用药对治疗室性期前收缩经验[J].辽宁中医杂志，2019，47（3）：51-53.
[19] 王颖，刘睿，周亚滨.周亚滨教授运用药对组合思想治疗心力衰竭经验[J].中国中医急症，2020，29（4）：711-713.
[20] 王颖，刘睿，周亚滨.周亚滨教授运用药对治疗缓慢性心律失常[J].吉林中医药，2020，40（4）：454-456.
[21] 张树涌，邱峻，林观康，等.桑白皮汤加减治疗慢性阻塞性肺疾病急性加重期痰热型的临床效果观察[J].中外医学研究，2019，17（22）：11-13.
[22] 张立康，王作顺.苓桂术甘汤临床应用研究概况[J].湖南中医杂志，2019，35（9）：181-182.
[23] 刘宁，赵进喜，贾海忠，等.茯苓泽泻，淡渗降浊；猪苓滑石，利水清热[J].环球中医药，2019，12（7）：1043-1045.
[24] 杨俊丽，黄丽丹，张亚中，等.萹蓄的研究进展[J].安徽医药，2016，20（6）：1025-1029.
[25] 张龙辉.辨证治疗Ⅲ型前列腺炎57例观察[J].浙江中医杂志，2018，53（11）：810.
[26] 张翠英，章洪，任伟光.UPLC-MS/MS测定丹参川芎对药中4种酚酸类成分在大鼠血浆和心脏组织的药代动力学[J].中国中药杂志，2019，44（19）：4257-4262. |
|
|
|
